| Expression pattern: |
UP |
| Associated gene: |
PDPK1 |
| Associated microRNA: |
miR-1183 |
| Biological function: |
Promotes NSCLC cell viability, proliferation, invasion, tumor growth, and gefitinib resistance. |
| Molecular mechanism: |
hsa_circ_0004015 functions as a miR-1183 sponge to relieve miR-1183-mediated repression of PDPK1, thereby promoting NSCLC progression and TKI resistance. |
| Biological pathway or process: |
proliferation (promotes); invasion (promotes); drug resistance (promotes); ceRNA regulation (other) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; Clinical Sample Validation; Transfection; MTT; CCK8; Colony Formation Assay; Transwell Assay; In Vivo Animal Model; Luciferase Reporter Assay; RNA Pull-Down; IF (Immunofluorescence); Western Blot; Survival Analysis; Bioinformatics Analysis |
| Clinical significance: |
High hsa_circ_0004015 expression is associated with poor overall survival and correlates with differentiation grade, invasion, and TNM stage in NSCLC patients. |
| Description: |
hsa_circ_0004015 is up-regulated in NSCLC tissues and cell lines and is associated with poorer overall survival. Functionally, it promotes NSCLC cell viability, proliferation, invasion, xenograft growth, and gefitinib resistance. Mechanistically, it acts through the miR-1183/PDPK1 regulatory axis, consistent with a ceRNA-like oncogenic role. |
| Confidence score: |
0.7761 |